Erratum to: NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin
Main Authors: | Dong Suwei, Zeng Liang, Liu Zhimin, Li Ruilei, Zou Yingying, Li Zhen, Ge Chunlei, Lai Zhangchao, Xue Yuanbo, Yang Jinyan, Li Gaofeng, Song Xin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-02-01
|
Series: | Journal of Hematology & Oncology |
Online Access: | http://link.springer.com/article/10.1186/s13045-016-0239-4 |
Similar Items
-
Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation in vitro and in nude mouse xenografts
by: Chunlei Ge, et al.
Published: (2019-01-01) -
Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
by: Chunlei Ge, et al.
Published: (2017-12-01) -
NLK is a novel therapeutic target for PTEN deficient tumour cells.
by: Ana M Mendes-Pereira, et al.
Published: (2012-01-01) -
Lentivirus-mediated knockdown of NLK inhibits small-cell lung cancer growth and metastasis
by: Lv MT, et al.
Published: (2016-11-01) -
Nemo-Like Kinase (NLK) Is a Pathological Signaling Effector in the Mouse Heart.
by: Ruijie Liu, et al.
Published: (2016-01-01)